Skip to content

About
Platform
Projects
Investors
Contact
English
English 繁體中文

About
About Medeon Team Company History
Platform
Projects
Overview Cross-Seal Urocross Duett PUMA ClickClean AbClose
Investors
Financials Corporate Governance Announcements News and Events Shareholder Meeting
Contact
Contact Us Join Us

English 繁體中文

Pre-Listing Performance Presentations for Initial Securities Listing

Posted on 2019-03-16 by Goodall.Ku

Post navigation

本公司受邀參加永豐金證券及證券櫃檯買賣中心聯合舉辦之「2017年潛力產業投資論壇」Medeon Biodesign Receives FDA 510(k) Clearance for Abclose™ – Laparoscopic Port Site Closure Device

發佈留言取消回覆

很抱歉，必須登入網站才能發佈留言。

Search

近期留言

彙整

分類

沒有分類

其他操作

登入
訂閱網站內容的資訊提供
訂閱留言的資訊提供
WordPress.org 台灣繁體中文

About

Platform
- What We Provide

Projects

Investors

Contact
- Contact Us
- Join Us

- Join us now:
- recruit@medeonbio.com
- Tel: +886 2 2881 6686
- Fax: +886 2 2881 6907

Copyright © 2019 Medeon Biodesign, Inc. All right reserved.